Conference Coverage > ACG 2015
Oct 19, 2015 | Gale Scott
With the ever-growing arsenal of antivirals to cure hepatitis C infection, physicians still have to be mindful of which of the six hepatitis virus genotypes their patient has. No drug work for all genotypes.
That could change next year. The pan-virals are coming.
Speaking at a symposium on treatments for hepatitis C at the American College of Gastroenterology Annual Scientific Meeting in Honolulu Oct 18, Mitchell Shiffman, MD, director of the Liver Institute of Virginia, Bon Secours Health System, Richmond, VA, said the newest drug candidates are expected to work on all genotypes of the virus.
No comments:
Post a Comment